Skip to content
Events

Details

The convergence of genomics, AI, and population-scale research is opening new frontiers in cardiovascular genomics. In this PMWC panel, NIH, Henry Ford Health, and Illumina experts discuss genomics, large-scale population studies, AI, and precision medicine approaches in cardiovascular research. The conversation explores how these tools may support earlier risk characterization, therapeutic target discovery, and translational insights across selected cardiovascular research settings. Watch the recording to hear how research and healthcare leaders are shaping the future of precision cardiovascular research.
Speakers

Damon Hostin, Illumina, moderates a panel discussion on precision cardiology with David Lanfear (Henry Ford Health) and Ronit Yarden (NIH/NHLBI).

Fill Out Form to Access Webinar
Date & Time
5 Mar 2026
Topic
Pharmacogenomics
Watch Now
For Research Use Only

Not for use in diagnostic procedures.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.